varenicline + placebo
ApprovedUNKNOWN 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Smoking
Conditions
Smoking
Trial Timeline
Jun 1, 2008 → Jun 1, 2011
NCT ID
NCT00937508About varenicline + placebo
varenicline + placebo is a approved stage product being developed by Pfizer for Smoking. The current trial status is unknown. This product is registered under clinical trial identifier NCT00937508. Target conditions include Smoking.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (20)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02856581 | Phase 3 | Terminated |
| NCT01934023 | Phase 2 | Completed |
| NCT01850953 | Approved | Completed |
| NCT01639560 | Approved | Completed |
| NCT01244061 | Approved | Completed |
| NCT01078298 | Approved | Completed |
| NCT01071187 | Phase 2 | UNKNOWN |
| NCT01010204 | Approved | Completed |
| NCT00992771 | Phase 2 | Completed |
| NCT00918307 | Phase 3 | Completed |
| NCT00977249 | Phase 2/3 | UNKNOWN |
| NCT00744978 | Phase 2 | Completed |
| NCT00803868 | Phase 2/3 | Terminated |
| NCT00835900 | Phase 2 | Completed |
| NCT00944554 | Approved | Completed |
| NCT00749944 | Approved | Completed |
| NCT00747643 | Pre-clinical | Completed |
| NCT00937508 | Approved | UNKNOWN |
| NCT00595868 | Phase 2 | Completed |
| NCT00602927 | Pre-clinical | Completed |
Competing Products
20 competing products in Smoking